Post-ERCP pancreatitis (PEP) induced by retrograde infusion of radiocontrast at high pressure (14, 15) was used to determine if pretreatment with the renalase peptide RP81 containing the RP220 area was histologically protective (Fig. 2). The gene discussed is RNLS; the disease is pancreatitis.